Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.04B | 4.48B | 3.02B | 2.84B | 3.74B | Gross Profit |
4.84B | 4.48B | 3.02B | 2.84B | 3.74B | EBIT |
993.44M | 384.55M | 268.79M | 101.15M | 123.05M | EBITDA |
804.33M | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
941.04M | 804.87M | 516.20M | 268.34M | 1.14B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.97B | 6.29B | 6.84B | 4.37B | 3.98B | Total Assets |
56.63B | 57.29B | 58.89B | 51.45B | 50.56B | Total Debt |
7.73B | 8.17B | 8.17B | 7.51B | 9.03B | Net Debt |
-6.97B | 1.88B | 1.32B | 3.14B | 5.05B | Total Liabilities |
51.74B | 52.36B | 53.56B | 46.47B | 45.96B | Stockholders Equity |
5.47B | 4.48B | 4.79B | 4.41B | 4.03B |
Cash Flow | Free Cash Flow | |||
112.47M | 960.40M | 1.28B | -386.64M | 1.71B | Operating Cash Flow |
131.45M | 990.74M | 1.29B | -373.31M | 1.75B | Investing Cash Flow |
-209.37M | -3.23B | -3.42B | 700.94M | -5.58B | Financing Cash Flow |
-372.06M | 1.78B | 4.64B | -1.08B | 3.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £2.35B | 11.66 | 40.24% | 5.31% | 2.95% | 9.84% | |
80 Outperform | £1.31B | 14.30 | 37.13% | 0.59% | 18.79% | 4.95% | |
76 Outperform | £3.74B | 10.97 | 19.85% | 4.34% | 6.34% | 30.64% | |
74 Outperform | £1.97B | 12.19 | 8.13% | 5.99% | 2.63% | 132.46% | |
67 Neutral | £8.98B | ― | ― | ― | ― | ||
64 Neutral | $12.74B | 9.85 | 7.88% | 17015.07% | 12.17% | -6.02% | |
62 Neutral | £8.98B | 6.73 | 12.50% | 7.28% | -3.32% | -31.32% |